IndusInd Bank
BSE SENSEX
35,160
S&P CNX
10,739
2 May 2018
Update
| Sector:
Financials
CMP: INR1,872
TP: INR2,150 (+15%)
Buy
BHAFIN’s performance on track; earnings to accelerate post-merger
Expect RoA/RoE to recover to 2.2%/20.3% by FY20
Stock Info
Bloomberg
Equity Shares (m)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
M.Cap. (INR b)
M.Cap. (USD b)
Avg Val, INRm
Free float (%)
Financials Snapshot (INR b)
2018 2019E
Y/E Mar
NII
OP
NP
NIM (%)
EPS (INR)
EPS Gr. (%)
BV/Sh. (INR)
RoE (%)
RoA (%)
P/E (X)
P/BV (X)
P/ABV (X)
75.0
66.6
36.1
4.2
60.2
25.2
394.1
16.5
1.8
31.1
4.8
4.8
111.1
98.2
53.5
4.7
83.0
37.9
452.9
19.6
2.1
22.6
4.1
4.2
IIB IN
600.2
1898 / 1375
2/11/13
1125
17.5
1986.0
85.0
2020E
145.2
131.4
72.8
4.7
104.4
25.8
577.9
20.3
2.2
17.9
3.2
3.3
After successfully completing three planning cycles, IndusInd Bank (IIB) has now
entered the fourth planning cycle (FY18-20). Besides delivering healthy profitability
and gaining market share in the existing businesses, it intends to further develop its
long-cherished livelihood financing theme in this cycle.
IIB has already taken a first step toward this by announcing a merger with its business
correspondent (BC) partner, Bharat Financial Inclusion (BHAFIN). It will be able to
leverage BHAFIN’s rural network, and thus, provide last-mile financing to villages
without incurring additional cost.
We expect IIB to report healthy acceleration in earnings over FY18-20 (as the
impending merger with BHAFIN gets concluded) and project RoA/RoE of 2.2%/20.3%
in FY20. Our forecasts are premised on expectations of steady expansion in margins
(FY20E: 4.7%), an improvement in the C/I ratio (by 190bp) and controlled credit cost.
We reiterate our Buy rating on IIB, with a target price of INR2,150 (3.8x FY20E ABV).
BHAFIN’s performance on track; demonetization impact waning
BHAFIN has orchestrated an impressive turnaround, led by strong performance
across operating parameters. It delivered AUM/PAT growth of 38% /57% in FY18,
while the GNPL/NNPL ratios declined to 2.4%/0.1% from 6%/2.7% in FY17.
Cumulative collection efficiency for loans disbursed post 1st January 2017 stands at
99.8%, indicating normalization of on-the-ground operations. Margins have been
largely stable, while a reduction in funding cost and an improvement in operating
leverage (cost-income ratio is down to 50% from 74% in FY14) could provide a
booster to earnings growth. BHAFIN has guided for AUM/earnings growth of
43%/36% in FY19.
Merger with BHAFIN to help attain last-mile rural connectivity
IIB intends to leverage BHAFIN’s rural presence to establish an extensive rural
distribution network in ~100,000 villages, with at least one customer touch point
within a 0.5km radius of these villages. The bank also plans to capitalize on the
cross-sell opportunities by mining BHAFIN’s customer base. The focus areas here
would be savings accounts, recurring deposits, partnerships for two-wheeler and
home improvement loans, and PSLC fee income opportunities from an enhanced
loan base qualifying for PSL. We also note that IIB is in the process of running a few
pilot projects to assess the viability of these initiatives (refer Exhibit 16 for more
details).
Shareholding pattern (%)
As On
Mar-18 Dec-17 Mar-17
Promoter
DII
FII
Others
15.0
10.0
57.2
17.8
15.0
11.7
55.3
18.0
15.0
12.3
54.2
18.6
FII Includes depository receipts
Stock Performance (1-year)
IndusInd Bank
Sensex - Rebased
1,950
1,800
1,650
1,500
1,350
Enough levers to achieve ‘Planning Cycle IV’ targets
IIB is aiming to achieve 25-30% loan growth in its Planning Cycle IV (FY17-20). After
achieving 26%+ loan book CAGR over FY12-18, the bank continues witnessing strong
traction across product lines. IIB sees significant headroom for growth to meet its
target from the partnership with BHAFIN. Besides the core business (wherein the
trends are strong in both corporate and vehicle financing segments), IIB anticipates
growth kicker from two areas: (1) microfinance business is re-entering the growth
phase after tiding over asset quality issues post demonetization, and
Research Analyst: Nitin Aggarwal
(Nitin.Aggarwal@MotilalOswal.com); +91 22 3982 5540
| Anirvan Sarkar
(Anirvan.Sarkar@MotilalOswal.com); +91 22 3982 5505
Alpesh Mehta
(Alpesh.Mehta@MotilalOswal.com); +91 22 3982 5415
| Parth Gutka
(Parth.Gutka@motilaloswal.com); +91 22 3010 2746
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.